ArticleBreast cancer research and treatment2021

Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.

Ben P Haynes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.